Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.

MLA

Storti, P., et al. “Galectin-1 Suppression Delineates a New Strategy to Inhibit Myeloma-Induced Angiogenesis and Tumoral Growth in Vivo.” Leukemia, vol. 30, no. 12, Dec. 2016, pp. 2351–63. EBSCOhost, https://doi.org/10.1038/leu.2016.137.

APA

Storti, P., Marchica, V., Airoldi, I., Donofrio, G., Fiorini, E., Ferri, V., Guasco, D., Todoerti, K., Silbermann, R., Anderson, J. L., Zhao, W., Agnelli, L., Bolzoni, M., Martella, E., Mancini, C., Campanini, N., Noonan, D. M., Petronini, P. G., Neri, A., … Giuliani, N. (2016). Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo. Leukemia, 30(12), 2351–2363. https://doi.org/10.1038/leu.2016.137

Chicago

Storti, P, V Marchica, I Airoldi, G Donofrio, E Fiorini, V Ferri, D Guasco, et al. 2016. “Galectin-1 Suppression Delineates a New Strategy to Inhibit Myeloma-Induced Angiogenesis and Tumoral Growth in Vivo.” Leukemia 30 (12): 2351–63. doi:10.1038/leu.2016.137.